Northside Hospital - Northside First in Georgia to Perform New Treatment for PAD

Northside First in Georgia to Perform New Treatment for PAD

Posted on: October 29, 2014


First and only FDA-approved drug coated balloon is now available for patients
Atlanta, Georgia – Northside Hospital Healthcare System is the first in Georgia to offer a new state-of-the-art treatment for peripheral arterial disease (PAD), a disease that creates blockages caused by plaque build-up in arteries that carry blood to the head, organs and limbs.

The LUTONIX® 035 Drug Coated Balloon PTA Catheter (DCB) is the first and only treatment of its kind approved by the U.S. Food and Drug Administration (FDA).  Dr. Joseph Ricotta performed Georgia’s first DCB procedure on October 15, 2014 at Northside Hospital-Forsyth in Cumming.

Dr. Ricotta is the chair of vascular surgery and endovascular therapy and the medical director of vascular services of the Northside Hospital Heart & Vascular Institute.

“We are committed to bringing cutting-edge technology and innovations in care to our patients, and it is exciting to be the first hospital in Georgia to offer this new treatment,” said Dr. Ricotta, “The Lutonix DCB is an advanced first-line therapy for treating blockages without completely ruling out other treatment options in the future, which is a key consideration when offering patients the best treatment possible.”

PAD in the femoropopliteal artery, a potentially life-threatening condition, affects millions of Americans by narrowing arteries and reducing blood flow to the limbs, according to American Heart Association (AHA) estimates.  Patients with PAD in the femoropopliteal arteries are at risk for lower-extremity amputation, particularly in people over the age of 50.  Minimally-invasive endovascular procedures such as angioplasty balloons, stents, medications and vascular bypass surgery are some of the accepted ways to treat PAD, but these options may be limited depending on the type of arterial blockage.

Successful treatment of PAD leads to improved blood flow (patency) for longer periods of time. The LUTONIX® 035 DCB uniquely combines an angioplasty balloon coated with a low dose of Paclitaxel to improve blood flow in blocked vessels in the legs.

In addition to its pioneering treatment with LUTONIX®, the Northside Hospital Heart & Vascular Institute has broken new ground in the field of robotic endovascular surgery -- it recently performed the first robotic endovascular case in Georgia. It also is the first program in the nation with FDA approval to treat high-risk patients with custom-modified endografts for thoracoabdominal aortic aneurysm.

A team of board-certified physicians, specialty-trained nurses and technologists at the Northside Hospital Heart & Vascular Institute has the highest level of expertise in diagnosing and treating disorders like aortic aneurysms, stroke, cardiac and vascular artery blockages, and heart attacks.  

Read more about Northside's heart & vascular services.

Filed under: Latest News & Technology,


Northside Hospital Atlanta

1000 Johnson Ferry Road NE
Atlanta, GA 30342
(404) 851-8000

Northside Hospital Cherokee

450 Northside Cherokee Blvd.
Canton, GA 30115
(770) 224-1000

Northside Hospital Duluth

3620 Howell Ferry Road
Duluth, GA 30096
(678) 312-6800

Northside Hospital Forsyth

1200 Northside Forsyth Drive
Cumming, GA 30041
(770) 844-3200

Northside Hospital Gwinnett

1000 Medical Center Blvd.
Lawrenceville, GA 30046
(678) 312-1000

Copyright © 2020 Northside Hospital